Dataset from A Phase I/II Open Label, Multicenter Study of PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00007348
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this Phase I/II study is to evaluate safety, pharmacokinetics, and preliminary
efficacy of the investigational drug PLX3397 in subjects with unresectable or metastatic
KIT-mutated melanoma.
创建时间：
2024-11-26
